These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27577975)

  • 1. Structural aspects of small-molecule inhibition of methyllysine reader proteins.
    Milosevich N; Warmerdam Z; Hof F
    Future Med Chem; 2016 Sep; 8(13):1681-702. PubMed ID: 27577975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyllysine binding domains: Structural insight and small molecule probe development.
    Teske KA; Hadden MK
    Eur J Med Chem; 2017 Aug; 136():14-35. PubMed ID: 28478342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Inhibitors of Epigenetic Methyllysine Reader Proteins.
    Milosevich N; Hof F
    Biochemistry; 2016 Mar; 55(11):1570-83. PubMed ID: 26650180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone peptide microarray screen of chromo and Tudor domains defines new histone lysine methylation interactions.
    Shanle EK; Shinsky SA; Bridgers JB; Bae N; Sagum C; Krajewski K; Rothbart SB; Bedford MT; Strahl BD
    Epigenetics Chromatin; 2017; 10():12. PubMed ID: 28293301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for methyllysine-binding aromatic cages.
    Vann KR; Vishweshwaraiah YL; Dokholyan NV; Kutateladze TG
    Biochem J; 2021 Oct; 478(19):3613-3619. PubMed ID: 34624071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical tools targeting readers of lysine methylation.
    Ortiz G; Kutateladze TG; Fujimori DG
    Curr Opin Chem Biol; 2023 Jun; 74():102286. PubMed ID: 36948085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL.
    Yang L; Liu Y; Fan M; Zhu G; Jin H; Liang J; Liu Z; Huang Z; Zhang L
    Eur J Med Chem; 2019 Nov; 182():111656. PubMed ID: 31494467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of Methylation State Specific 3xMBT Domain Using ELISA Screening.
    Cohen DO; Duchin S; Feldman M; Zarivach R; Aharoni A; Levy D
    PLoS One; 2016; 11(4):e0154207. PubMed ID: 27111853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting non-bromodomain chromatin readers.
    Arrowsmith CH; Schapira M
    Nat Struct Mol Biol; 2019 Oct; 26(10):863-869. PubMed ID: 31582844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated methyl readers: Functional communications in cancer.
    Park IG; Jeon M; Kim H; Lee JM
    Semin Cancer Biol; 2022 Aug; 83():88-99. PubMed ID: 33753223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.
    James LI; Korboukh VK; Krichevsky L; Baughman BM; Herold JM; Norris JL; Jin J; Kireev DB; Janzen WP; Arrowsmith CH; Frye SV
    J Med Chem; 2013 Sep; 56(18):7358-71. PubMed ID: 24040942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical probes of histone lysine methyltransferases.
    Kaniskan HÜ; Jin J
    ACS Chem Biol; 2015 Jan; 10(1):40-50. PubMed ID: 25423077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting epigenetic protein-protein interactions with small-molecule inhibitors.
    Linhares BM; Grembecka J; Cierpicki T
    Future Med Chem; 2020 Jul; 12(14):1305-1326. PubMed ID: 32551894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
    Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
    ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomains and their pharmacological inhibitors.
    Gallenkamp D; Gelato KA; Haendler B; Weinmann H
    ChemMedChem; 2014 Mar; 9(3):438-64. PubMed ID: 24497428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.
    Wigle TJ; Herold JM; Senisterra GA; Vedadi M; Kireev DB; Arrowsmith CH; Frye SV; Janzen WP
    J Biomol Screen; 2010 Jan; 15(1):62-71. PubMed ID: 20008125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mind the methyl: methyllysine binding proteins in epigenetic regulation.
    Wagner T; Robaa D; Sippl W; Jung M
    ChemMedChem; 2014 Mar; 9(3):466-83. PubMed ID: 24449612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A.
    Huang Y; Fang J; Bedford MT; Zhang Y; Xu RM
    Science; 2006 May; 312(5774):748-51. PubMed ID: 16601153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing Spindlin1 small-molecule inhibitors by using protein microarrays.
    Bae N; Viviano M; Su X; Lv J; Cheng D; Sagum C; Castellano S; Bai X; Johnson C; Khalil MI; Shen J; Chen K; Li H; Sbardella G; Bedford MT
    Nat Chem Biol; 2017 Jul; 13(7):750-756. PubMed ID: 28504676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromodomain biology and drug discovery.
    Zaware N; Zhou MM
    Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.